Adamczyk M, Krasowska D. Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs. Dermatology Review/Przegląd Dermatologiczny. 2023;110(6):698-702. doi:10.5114/dr.2023.136325.
APA
Adamczyk, M., & Krasowska, D. (2023). Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs. Dermatology Review/Przegląd Dermatologiczny, 110(6), 698-702. https://doi.org/10.5114/dr.2023.136325
Chicago
Adamczyk, Michał, and Dorota Krasowska. 2023. "Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs". Dermatology Review/Przegląd Dermatologiczny 110 (6): 698-702. doi:10.5114/dr.2023.136325.
Harvard
Adamczyk, M., and Krasowska, D. (2023). Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs. Dermatology Review/Przegląd Dermatologiczny, 110(6), pp.698-702. https://doi.org/10.5114/dr.2023.136325
MLA
Adamczyk, Michał et al. "Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs." Dermatology Review/Przegląd Dermatologiczny, vol. 110, no. 6, 2023, pp. 698-702. doi:10.5114/dr.2023.136325.
Vancouver
Adamczyk M, Krasowska D. Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs. Dermatology Review/Przegląd Dermatologiczny. 2023;110(6):698-702. doi:10.5114/dr.2023.136325.
